28.02.2013 Views

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

998 An Li<br />

This discussion is intended to provide an easy approach for predicting the effect <strong>of</strong><br />

cosolvents, which are frequently involved in pharmaceutical and environmental applications,<br />

on the solubility <strong>of</strong> organic chemicals. The starting point is the widely used log-linear<br />

model.<br />

14.21.2.2 Applications <strong>of</strong> cosolvency in pharmaceutical sciences and<br />

industry<br />

Although many drugs are formulated and administrated in solid, vapor, powder, or other<br />

forms, using solutions as drug delivery vehicle has significant advantages. Most<br />

parenterally administered medicines are in the form <strong>of</strong> liquid solution, and for intravenous<br />

injection, liquid form dosage is the only possible form. However, drugs are usually designed<br />

with little concern about their level <strong>of</strong> solubility in solution. It is the task <strong>of</strong> pharmaceutical<br />

formulators to find appropriate forms for the drug to be effectively delivered into<br />

biological systems.<br />

The phenomena <strong>of</strong> cosolvency have been studied for more than a century by pharmaceutical<br />

scientists. Numerous experimental data are published in the literature, and most <strong>of</strong><br />

the models mentioned in the introduction section have been developed from pharmaceutical<br />

research. In addition to the need <strong>of</strong> solubilizing drugs which are poorly water-soluble, controlling<br />

the dissolution <strong>of</strong> drugs administered as solids to optimize therapeutic activity also<br />

demands an improved understanding <strong>of</strong> drug solubilization. Approaches that may be pursued<br />

to enhance drug solubility in a liquid dosage formulation include adjusting pH, adding<br />

surfactants, cosolvents, or complexation agents. Choice <strong>of</strong> these techniques depends primarily<br />

on the drug’s chemical structure and physicochemical properties. For example, control<br />

<strong>of</strong> pH is applicable only when the drug is an electrolyte. To solubilize nonelectrolyte<br />

drugs, the use <strong>of</strong> cosolvents outweighs surfactants and complexing agents. 20<br />

Cosolvents that are routinely used in drug formulation include ethanol, propylene glycol,<br />

polyethylene glycol, and glycerin. Examples <strong>of</strong> pharmaceutical products containing<br />

these cosolvents are summarized in Table 14.21.2.1.<br />

Table 14.21.2.1. Selected pharmaceutical products containing cosolvents<br />

Trade Name Cosolvent vol% Manufacturer Type<br />

Aclovate cream Propylene glycol Schering Topical<br />

Alurate elixir Ethanol 20 Roche Oral liquid<br />

Amidate Propylene glycol 35 Abbott Parenteral<br />

Amphojel Glycerin Wyeth-Ayerst Oral<br />

Apresoline Propylene glycol 10 Ciba Parenteral<br />

Aristocort cream Propylene glycol Fujisawa Topical<br />

Ativan<br />

Polyethylene glycol<br />

Propylene glycol<br />

20<br />

80<br />

Wyeth-Ayerst Parenteral<br />

Bentyl syrup Propylene glycol Lakeside Oral<br />

Brevibioc Ethanol 25 DuPont Parenteral<br />

Cleocin T lotion Glycerin Upjohn Topical

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!